Proven Measured GFR for Preclinical Studies

  • Transdermal, thus No Sampling Required
  • Longitudinal Measurements Captured
  • Animal Not Restrained During Monitoring
  • Miniature Detection Device Used in All Animals
  • Validated Fluorescent Tracer Agents Employed
  • Over 100 Peer Reviewed Publications and Conference Abstracts


Successful Use in Nephrology Research

sellsheet_image1MediBeacon technology is used by leading medical schools, academic centers, research institutes, and pharmaceutical companies worldwide to enhance preclinical assessment of kidney therapeutics, evaluate nephrotoxicity, and gain fundamental understanding of kidney function in animals.

Research using the MediBeacon preclinical product has been featured in numerous posters presented at previous American Society of Nephrology (ASN) Kidney Week meetings. In all there are over 100 published studies in which this transdermal mGFR technique was used (peer reviewed and conference abstracts).


Preclinical Device – Technical Specifications

The instrument contains light emitting diodes capable of exciting the fluorescent tracer agent and a photodiode that collects the emission light.

After amplification and digitization, the data sets are stored in the internal memory of the device. The data is later transferred to a PC via USB connection. A basic PC software package is provided with the device. An advanced evaluation software (Preclinical Data Studio) is sold separately.


MediBeacon Preclinical Transdermal GFR Monitor – Product Brochure – US (PDF) 

MediBeacon Preclinical Transdermal GFR Monitor – Product Brochure – A4 (PDF)

Contact Us

for more information on preclinical products.

This device is not approved for human use.